Stock IP INTER PHARMA
Add to a list
To use this feature you must be a member
Log inSign up

Financials Inter Pharma

Equities

IP

TH9474010005

Pharmaceuticals

End-of-day quote Thailand S.E.
Other stock markets
 03:30:00 15/05/2024 am IST 		5-day change 1st Jan Change
6.25 THB -2.34% Intraday chart for Inter Pharma -6.72% +12.85%
14/05 Inter Pharma Public Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
26/04 Inter Pharma Public Company Limited Approves Dividend for the Year 2023, Payable on May 24, 2024 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 2,699 5,811 5,513 3,353 3,783 -
Enterprise Value (EV) 1 2,699 5,811 5,513 3,353 3,783 3,783
P/E ratio 50.4 x 54.2 x 40.7 x 66.2 x 22.6 x 18.1 x
Yield 0.18% 1.03% - - 2.26% 2.76%
Capitalization / Revenue 6.1 x 6.4 x 3.62 x 1.88 x 1.67 x 1.4 x
EV / Revenue 6.1 x 6.4 x 3.62 x 1.88 x 1.67 x 1.4 x
EV / EBITDA 34.3 x 36.3 x 24.5 x 17.6 x 12.3 x 10.7 x
EV / FCF -127 x -21.9 x 47.6 x - 25.9 x 21.6 x
FCF Yield -0.79% -4.57% 2.1% - 3.86% 4.63%
Price to Book - - 2.86 x - - -
Nbr of stocks (in thousands) 4,68,650 4,84,267 6,05,346 6,05,346 6,05,346 -
Reference price 2 5.758 12.00 9.108 5.538 6.250 6.250
Announcement Date 25/02/21 25/02/22 28/02/23 01/03/24 - -
1THB in Million2THB
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 442.1 908.6 1,523 1,781 2,263 2,708
EBITDA 1 78.76 160 225.4 190.1 307 354
EBIT 1 73.66 133.4 160.6 91.86 243 296
Operating Margin 16.66% 14.68% 10.54% 5.16% 10.74% 10.93%
Earnings before Tax (EBT) 1 77.2 137.7 147.6 81.37 233 287
Net income 1 53.78 105.2 119.2 50.79 169 209
Net margin 12.16% 11.58% 7.83% 2.85% 7.47% 7.72%
EPS 2 0.1143 0.2215 0.2240 0.0837 0.2769 0.3446
Free Cash Flow 1 -21.27 -265.7 115.7 - 146 175
FCF margin -4.81% -29.24% 7.6% - 6.45% 6.46%
FCF Conversion (EBITDA) - - 51.34% - 47.56% 49.44%
FCF Conversion (Net income) - - 97.05% - 86.39% 83.73%
Dividend per Share 2 0.0103 0.1231 - - 0.1415 0.1723
Announcement Date 25/02/21 25/02/22 28/02/23 01/03/24 - -
1THB in Million2THB
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales - - 441.1 - -
EBITDA - - 70.61 - -
EBIT - - 38.75 - -
Operating Margin - - 8.78% - -
Earnings before Tax (EBT) - - 41.53 - -
Net income 1 36.06 30.45 28.23 40.06 11.34
Net margin - - 6.4% - -
EPS - 0.0554 0.0455 0.0677 -
Dividend per Share - - - - -
Announcement Date 25/02/22 11/11/22 28/02/23 12/05/23 11/08/23
1THB in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -21.3 -266 116 - 146 175
ROE (net income / shareholders' equity) 11.6% 17.1% 8.87% - 8.7% 10.3%
ROA (Net income/ Total Assets) 8.43% 10.1% 5.48% - 5.2% 6%
Assets 1 637.9 1,042 2,176 - 3,250 3,483
Book Value Per Share - - 3.180 - - -
Cash Flow per Share - - - - - -
Capex 1 12.5 224 27.4 - 10 10
Capex / Sales 2.82% 24.67% 1.8% - 0.44% 0.37%
Announcement Date 25/02/21 25/02/22 28/02/23 01/03/24 - -
1THB in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Inter Pharma

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.25
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
INTER PHARMA Stock Inter Pharma
+12.85% 106M
NOVO NORDISK A/S Stock Novo Nordisk A/S
+31.37% 588B
JOHNSON & JOHNSON Stock Johnson & Johnson
-2.60% 364B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.83% 326B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.83% 239B
NOVARTIS AG Stock Novartis AG
+9.93% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-6.95% 200B
AMGEN INC. Stock Amgen Inc.
+10.77% 167B
PFIZER, INC. Stock Pfizer, Inc.
+0.10% 161B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. IP Stock
  4. Financials Inter Pharma
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW